WHO ICTRP trial

Research on the Clinical Value of AKR1B10 in the Stratified Diagnosis of…

ChiCTR2500109226 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting

Key facts

Trial ID ChiCTR2500109226
Public title Research on the Clinical Value of AKR1B10 in the Stratified Diagnosis of Pancreatic Cancer and Precancerous Lesions
Scientific title Research on the Clinical Value of AKR1B10 in the Stratified Diagnosis of Pancreatic Cancer and Precancerous Lesions
Primary sponsor West China Hospital, Sichuan University
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Not Recruiting
Study type Observational study
Countries China
Conditions PDAC;IPMN;MCN;chronic pancreatitis;SCN
Interventions Pancreatic Cancer Group:None;High-Risk Benign Lesion Group:None;Low-Risk Benign Lesion Group:None;Healthy Control Group:None
Registration date Sep 15, 2025
Target size Pancreatic Cancer Group:150;High-Risk Benign Lesion Group:150;Low-Risk Benign…
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations